Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain

Vaccine

Volumn 23, Issue 24, 2005, Pages 3196-3201

  Zhang, Chuan Hai ^a,b,f   Lu, Jia Hai ^c   Wang, Yi Fei ^a   Zheng, Huan Ying ^e   Xiong, Sheng ^a   Zhang, Mei Ying ^a   Liu, Xin Jian ^a   Li, Jiu Xiang ^a   Wan, Zhuo Yue ^e   Yan, Xin Ge ^e   Qi, Shu Yuan ^f   Cui, Zhiyong ^g   Zhang, Biliang ^d,g  

^a JINAN UNIVERSITY   (China)

^b WEST ANHUI UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^e GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f SOUTH CHINA INSTITUTE OF BOTANY   (China)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Balb c mouse; Immunogenicity; Inactivated vaccine; SARS coronavirus (SARS CoV)

Indexed keywords

ALUMINUM HYDROXIDE; FREUND ADJUVANT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG POTENCY; DRUG SCREENING; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SARS CORONAVIRUS; SERODIAGNOSIS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS STRAIN; WESTERN BLOTTING;

EID: 20144387705     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.11.073     Document Type: Article

References (26)

1. C.H. Zhang, Y.F. Wang, M.Y. Zhang, and S.Y. Qi Recent progress in the studies on SARS and its pathogeny Chin Bull Life Sci 15 3 2003 129 133
2. K.W. Tsang, P.L. Ho, G.C. Ooi, W.K. Yee, T. Wang, and C.Y. Moira A cluster of cases of severe acute respiratory syndrome in Hong Kong N Engl J Med 348 20 2003 1977 1985
3. Update: outbreak of severe acute respiratory syndrome - Worldwide, 2003. Morb Mort Wkly Rep 2003;52(12):241-8.
4. J.S. Peiris, S.T. Lai, L.L. Poon, Y. Guan, L.Y. Yam, and W Lim Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 361 9366 2003 1319 1325
5. C. Drosten, S. Günther, W. Preiser, S. van der Werf, H.R. Brodt, and S. Becker Identification of a novel coronavirus in patients with severe acute respiratory syndrome N Engl J Med 348 20 2003 1967 1976
6. N.S. Zhong, B.J. Zheng, Y.M. Li, L.L. Poon, Z.H. Xie, and K.H. Chan Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China in February 2003 Lancet 362 9393 2003 1353 1358
7. T.G. Ksiazek, D. Erdman, C.S. Glodsmith, S.R. Zaki, T. Peret, and S. Emery A novel coronavirus associated with severe acute respiratory syndrome N Engl J Med 348 20 2003 1953 1966
8. P.A. Rota, M.S. Oberste, S.S. Monroe, W.A. Nix, R. Campagnoli, and J.P. Icenogle Characterization of a novel coronavirus associated with severe acute respiratory syndrome Science 300 5624 2003 1394 1399
9. Y.J. Ruan, C.L. Wei, L.A. Ee, V.B. Vega, H. Thoreau, and S.Y. Thoe Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection Lancet 361 9371 2003 1779 1785
10. M.A. Marra, S.J. Jones, C.R. Astell, R.A. Holt, A. Brooks-Wilson, and Y.S. Butterfield The genome sequence of the SARS-associated coronavirus Science 300 5624 2003 1399 1404
11. The Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004;303(5664):1666-9.
12. X. Zhang, H. Li, K. Zheng, Q.X. Chen, Z.Y. Wan, and J.C. Huang Isolation, identification and variance of a coronavirus from a imoutting SARS case Chin J Microbiol Immunol 23 6 2003 409 417
13. J.H. Lu, X.G. Yan, Z.M. Guo, H.Y. Zheng, X. Zhang, and Z.Y. Wan Establishment of SARS virus vaccine line Guangdong Med J (Chinese) 24 SARS Suppl. 2 2003 194 195
14. J.H. Lu, X.G. Yan, Y.F. Wang, H.Y. Zheng, Z.Y. Wan, and J. Li Study on the function in inactivating antigenicity of SARS coronavirus by formaldehyde Guangdong Med J (Chinese) 24 SARS Suppl. 2 2003 206 207
15. WHO. Manual for the virological investigation of polio. WHO/EPI/GEN/97.01. In: Neutralization test for polio antibodies. 1997:44-52.
16. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning - a laboratory manual 2nd ed. 1989 Cold Spring Harbor Laboratory Press
17. C.E. Theodore, and M. Martin Workshop summary: Aluminium in vaccines Vaccine 20 Suppl. 3 2002 1 3
18. C.J. Clements, and E. Griffiths The global impact of vaccines containing aluminium adjuvants Vaccine 20 Suppl. 3 2002 24 33
19. A.M. Krieg, G. Hartmann, and A.K. Yi Mechanism of activation of CpG DNA Curr Top Microbiol Immunol 247 2000 1 21
20. P.H. Nass, K.L. Elkins, and J.P. Weir Protective immunity against herpes somplex virus generated by DNA vaccination compared to natural infection Vaccine 19 11-12 2001 1538 1546
21. K. Johansen, U. Schroder, and L. Svensson Immunogenicity and peotective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants Vaccine 21 5-6 2003 368 375
22. T. Akagi, M. Kawamura, M. Ueno, K. Hiraishi, M. Adachi, and T. Serizawa Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice J Med Virol 69 2 2003 163 172
23. T. Zhou, H. Wang, D. Luo, T. Rowe, Z. Wang, and R.J. Hogan An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies J Virol 78 13 2004 7217 7226
24. T.W. Kim, J.H. Lee, C.F. Hung, S. Peng, R. Roden, and M.C. Wang Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus J Virol 78 9 2004 4638 4645
25. W.L. Liu, Y. Lu, and Y.H. Chen Bioinformatics analysis of SARS-CoV M protein provides information for vaccine development Prog Nat Sci 13 11 2003 844 847
26. L. Tang, J. Wang, E.D. Qin, Q.Y. Zhu, M. Yu, and Z.F. Ding Preparation, characterization and preliminary in vivo studies of inactivated SARS-CoV vaccine Chin Sci Bull 48 23 2003 2621 2625